Hopewell Therapeutics
Woburn
About Hopewell Therapeutics
Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing. It is intended to provide and services in the field of novel drug delivery systems. The technology developed by the company is based on novel synthetic lipid-based nanoparticles for nucleic acid delivery for gene therapy and gene editing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $42.6M
- Last round: Series Unknown (Sep 2025)
- Website: hopewell-tx.com
- Phone: 781-218-3318
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/hopewell-therapeutics-14603 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.